Aim: The goal of this work is to understand the cellular effects of advanced glycation end product (AGE)-modified protein on renal proximal tubule cells. Background: A major function of the proximal tubule is to reabsorb and process filtered proteins. Diabetes is characterized by increased quantities of tissue and circulating proteins modified by AGEs. Therefore in diabetes, plasma proteins filtered at the glomerulus and presented to the renal proximal tubule are likely to be highly modified by AGEs. Methods: The model system was electrically resistant polarized renal proximal tubular epithelial cells in monolayer culture. The model proteins comprise a well-characterized AGE, methylglyoxal-modified bovine serum albumin (MGO-BSA), and unmodified BSA. Results: Renal proximal tubular cells handle MGO-BSA and native BSA in markedly disparate ways, including differences in: (1) kinetics of binding, uptake, and intracellular accumulation, (2) processing and fragmentation, and (3) patterns of electrical conductance paralleling temporal changes in binding, uptake and processing. Conclusion: These differences support the idea that abnormal protein processing by the renal tubule can be caused by abnormal proteins, thereby forging a conceptual link between the pathogenic role of AGEs and early changes in tubular function that can lead to hypertrophy and nephropathy in diabetes.

Keywords:
Advanced glycation end product, Diabetic nephropathy, Renal proximal tubule cell, Methylglyoxal, Methylglyoxal-modified albumin
1.
Birn H, Christensen EI: Renal albumin absorption in physiology and pathology. Kidney Int 2006;69:440–449.
2.
Osicka TM, Houlihan CA, Chan JG, Jerums G, Comper WD: Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 2000;49:1579–1584.
3.
Gudehithlu K, Pegoraro A, Dunea G, Arruda A, Singh A: Degradation of albumin by the renal proximal tubule cells and the subsequent fate of its fragments. Kidney Int 2004;65:2113–2122.
4.
Tucker BJ, Rasch R, Blantz RC: Glomerular filtration and tubular reabsorption of albumin in preproteinuric and proteinuric diabetic rats. J Clin Invest 1993;92:686–694.
5.
Osicka T, Kiriazis Z, Pratt L, Jerums G, Comper W: Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats. Diabetologia 2001;44:230–236.
6.
Beisswenger PJ, Drummond KS, Nelson RG, Howell SK, Szwergold BS, Mauer M: Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes 2005;54:3274–3281.
7.
Layton G, Jerums G: Effect of glycation of albumin on its renal clearance in normal and diabetic rats. Kidney Int 1988;33:673–676.
8.
Londono I, Bendayan M: Glomerular handling of native albumin in the presence of circulating modified albumins by the normal rat kidney. Am J Physiol Renal Physiol 2005;289:F1201–F1209.
9.
Gugliucci A, Bendayan M: Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE peptides by renal proximal tubular cells. Diabetologia 1996;39:149–160.
10.
Saito A, Takeda T, Sato K, Hama H, Tanuma A, Kaseda R, Suzuki Y, Gejyo F: Significance of proximal tubular metabolism of advanced glycation end products in kidney diseases. Ann NY Acad Sci 2005;1043:637–643.
11.
Morcos M, Sayed A, Bierhaus A, Yard B, Waldherr R, Merz W, Kloeting I, Schleicher E, Mentz S, Ad el Baki R, Tritschler H, Kasper M, Schwenger V, Hamann A, Dugi K, Schmidt A-M, Stern D, Ziegler R, Haering H, Andrassay M, van der Woude F, Nawroth P: Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 2002;51:3532–3544.
12.
Oldfield M, Bach L, Forbes J, Nikolic-Paterson D, McRobert A, Thallas V, Atkins R, Osicka T, Jerums G, Cooper M: Advanced glycation end products cause epithelial myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001;108:1853–1863.
13.
Fan X, Subramaniam R, Weiss MF, Monnier VM: Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor-α secretion in raw 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor κB and intracellular reactive oxygen species formation. Arch Biochem Biophys 2003;409:274–286.
14.
Subramaniam R, Fan XJ, Scivittaro V, Yang J, Ha CE, Petersen CE, Surewicz WK, Bhagavan NV, Weiss MF, Monnier VM: Cellular oxidant stress and advanced glycation end products of albumin: caveats of the dichlorofluorescein assay. Arch Biochem Biophys 2002;400:15–25.
15.
Racusen L, Monteil C, Scrignoli A, Lucskay M, Marouillat S, Rhim J, Morin J-P: Cell lines with extended growth potential from human renal proximal tubule: characterization, response to inducers and comparison with established cell lines. J Lab Clin Med 1997;129:318–329.
16.
Orosz D, Woost P, Kolb R, Finesilver M, Jin W, Frisa P, Choo C, Yau C, Chan K, Resnick M, Douglas J, Edwards J, Jacobberger J, Hopfer U: Growth, immortalization, and differentiation potential of normal adult human proximal tubule cells. In Vitro Cell Dev Biol Anim 2004;40:22–34.
17.
Gekle M, Freudinger R, Mildenberger S: Inhibition of Na+-H+ exchanger-3 interferes with apical-receptor mediated endocytosis via vesicle fusion. J Physiol 2001;531.3:619–629.
18.
Park CH, Maack T: Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit. J Clin Invest 1984;73:767–777.
19.
Comper WD, Jerums G, Osicka TM: Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatography. Clin Biochem 2004;37:105–111.
20.
Donnelly SM: Accumulation of glycated albumin in end-stage renal failure: evidence for the principle of ‘physiological microalbuminuria’. Am J Kidney Dis 1996;28:62–66.
21.
Osicka TM, MacIsaac RJ, Jerums G, Comper WD: High prevalence of immuno-unreactive albumin in urine from diabetic patients with a low glomerular filtration rate and normoalbuminuria. Diabetes Care 2004;27:1515.
22.
Burne MJ, Panagiotopoulos S, Jerums G, Comper WD: Alterations in renal degradation of albumin in early experimental diabetes in the rat: a new factor in the mechanism of albuminuria. Clin Sci (Lond) 1998;95:67–72.
23.
Thomson S, Vallon V, Blantz R: Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004;286:F8–F15.
24.
Eddy AA: Proteinuria and interstitial injury. Nephrol Dial Transplant 2004;19:277–281.
25.
Li JH, Wang W, Huang XR, Oldfield M, Schmidt AM, Cooper ME, Lan HY: Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 map kinase signaling pathway. Am J Pathol 2004;164:1389–1397.
26.
Ahmed N, Babaei-Jadidi R, Howell SK, Beisswenger PJ, Thornalley PJ: Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia 2005;48:1590–1603.
27.
Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP: Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005;83:876–886.
28.
Saito A, Nagai R, Tanuma A, Hama H, Cho K, Takeda T, Yoshida Y, Toda T, Shimizu F, Horiuchi S, Gejyo F: Role of megalin in endocytosis of advanced glycation end products: implications for a novel protein binding to both megalin and advanced glycation end products. J Am Soc Nephrol 2003;14:1123–1131.
29.
Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, Pischetsrieder M, Stern D, Schmidt AM, D’Agati VD: Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 2000;11:1656–1666.
30.
Tojo A, Onozato M, Ha H, Kurihara H, Sakai T, Goto A, Fujita T, Endou H: Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats. Histochem Cell Biol 2001;116:269–276.
31.
Hopfer U, Woost PG, Jacobberger JW, Douglas JG: New methods for maintaining human renal epithelial cells and analyzing their ion transport functions: potential analysis of genetic disease. Ethn Health 1996;1:129–136.
32.
McDonough A, Biemesderfer D: Does membrane trafficking play a role in regulating the sodium/hydrogen exchanger isoform 3 in the proximal tubule? Curr Opin Nephrol Hypertens 2003;12:533–541.
33.
Baum M, Quigley R: Maturation of rat proximal tubule chloride permeability. Am J Physiol 2005;289:R1659–R1664.
34.
Hryciw DH, Lee EM, Pollock CA, Poronnik P: Molecular changes in proximal tubule function in diabetes mellitus. Clin Exp Pharmacol Physiol 2004;31:372–379.
35.
Abel M, Ritthaler U, Zhang Y, Deng Y, Schmidt AM, Greten J, Sernau T, Wahl P, Andrassy K, Ritz E, Waldherr R, Stern DM, Nawroth PP: Expression of receptors for advanced glycosylated end-products in renal disease. Nephrol Dial Transplant 1995;10:1662–1667.
36.
Rasch R, Norgaard J: Renal enlargement: Comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia 1983;25:280–287.
37.
Sebekova K, Schinzel R, Ling H, Simm A, Xiang G, Gekle M, Munch G, Vamvakas S, Heidland A: Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1. Cell Mol Biol (Noisy-le-grand) 1998;44:1051–1060.
38.
Xiang G, Schinzel R, Simm A, Sebekova K, Heidland A: Advanced glycation end products impair protein turnover in LLC-PK1: amelioration by trypsin. Kidney Int 2001;78:S53–S57.
39.
Shechter P, Boner G, Rabkin R: Tubular cell protein degradation in early diabetic renal hypertrophy. J Am Soc Nephrol 1994;4:1582–1587.
40.
Wihler C, Schafer S, Schmid K, Deemer EK, Munch G, Bleich M, Busch AE, Dingermann T, Somoza V, Baynes JW, Huber J: Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition. Diabetologia 2005;48:1645–1653.
41.
Xiang G, Schinzel R, Simm A, Munch G, Sebekova K, Kasper M, Niwa T, Schmitz C, Heidland A: Advanced glycation end products (ages)-induced expression of TGF-β1 is suppressed by a protease in the tubule cell line LLC-PK1. Nephrol Dial Transplant 2001;16:1562–1569.
42.
Malik B, Price SR, Mitch WE, Yue Q, Eaton DC: Regulation of epithelial sodium channels by the ubiquitin-proteasome proteolytic pathway. Am J Physiol Renal Physiol 2006;290:F1285–F1294.
43.
Stolzing A, Widmer R, Jung T, Voss P, Grune T: Degradation of glycated bovine serum albumin in microglial cells. Free Radic Biol Med 2006;40:1017–1027.
44.
Bulteau AL, Verbeke P, Petropoulos I, Chaffotte AF, Friguet B: Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 s proteasome degradation in vitro. J Biol Chem 2001;276:45662–45668.
45.
Gugliucci A, Menini T: The polyamines spermine and spermidine protect proteins from structural and functional damage by age precursors: a new role for old molecules? Life Sci 2003;72:2603–2616.
46.
Schmitt HP: ε-Glycation, APP and Aβ in ageing and Alzheimer disease: a hypothesis. Med Hypotheses 2006;66:898–906.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.